/

Empresas

Cu

No verificado

Curium

Sobre qué escribimos

Anuncios brevesFarmacéuticaGestión empresarial/Administración de EmpresasMedicina Salud Bienestar

12 Comunicados de prensa

Ver todos los comunicados de prensa

20/11/2025

Farmacéutica

CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

Fuente

Editor

1.00

0

19/11/2025

Farmacéutica

Gestión empresarial/Administración de Empresas

Medicina Salud Bienestar

Curium Announces First Commercial Doses of Diagnostic Radiopharmaceutical in Czech Republic and Slovakia for Patients with Prostate Cancer

Fuente

Editor

1.00

0

17/11/2025

Farmacéutica

Anuncios breves

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

Fuente

Editor

1.00

0

14/10/2025

Farmacéutica

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

Fuente

Editor

1.00

0

21/05/2025

Farmacéutica

Gestión empresarial/Administración de Empresas

Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals

Fuente

Editor

1.00

0

12/05/2025

Farmacéutica

Medicina Salud Bienestar

Anuncios breves

Curium receives marketing authorization in Switzerland for PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer

Fuente

Editor

1.00

0

10/04/2025

Farmacéutica

Curium strengthens its PET manufacturing capacity and expands European footprint with the acquisition of Nucleis

Fuente

Editor

1.00

0

27/03/2025

Farmacéutica

Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint

Fuente

Editor

1.00

0

30/01/2025

Farmacéutica

Anuncios breves

Gestión empresarial/Administración de Empresas

Curium Expands European Supply of Iodine-131 Diagnostic Capsules with New Partnership Agreement with Izotop

Fuente

Editor

1.00

0

28/01/2025

Farmacéutica

Anuncios breves

Curium Further Expands European Availability of PYLCLARI – an Innovative 18F-PSMA PET Radiopharmaceutical Indicated in Patients with Prostate Cancer

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0